Sanofi Teams Up With India to Make Cheap Antiretrovirals in South Africa
April 2, 2012
Under an arrangement announced Friday, French drugmaker Sanofi will partner with India's Hetero to manufacture low-cost antiretrovirals in South Africa. The move represents progress toward South Africa's goal of buying 80 percent of its ARVs from local sources, said Sanofi CEO Christopher Viehbacher. "There is a continuous supply shortage for critical medicines for HIV/AIDS. Only 50 percent of patients are able to receive treatment, and there is a real need for more locally manufactured and supplied affordable ARVs." To accommodate increased demand, Sanofi recently upgraded its factory north of Pretoria.
Agence France Presse
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)